Kestra Medical Technologies, Ltd.
KMTS
$26.07
-$0.33-1.25%
NASDAQ
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 07/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 35.85M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | 35.85M | |
| Cost of Revenue | -- | -- | -- | 30.34M | |
| Gross Profit | -- | -- | -- | 5.52M | |
| SG&A Expenses | -- | -- | -- | 71.70M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | -- | 116.96M | |
| Operating Income | -- | -- | -- | -81.11M | |
| Income Before Tax | -- | -- | -- | -89.32M | |
| Income Tax Expenses | -- | -- | -- | 12.50K | |
| Earnings from Continuing Operations | -- | -- | -- | -89.33 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | 439.00K | |
| Net Income | -- | -- | -- | -88.90M | |
| EBIT | -- | -- | -- | -81.11M | |
| EBITDA | -- | -- | -- | -69.52M | |
| EPS Basic | -- | -- | -- | -254.60 | |
| Normalized Basic EPS | -- | -- | -- | -142.12 | |
| EPS Diluted | -- | -- | -- | -254.60 | |
| Normalized Diluted EPS | -- | -- | -- | -142.12 | |
| Average Basic Shares Outstanding | -- | -- | -- | 59.76M | |
| Average Diluted Shares Outstanding | -- | -- | -- | 59.76M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |